Patent classifications
C07C309/51
Curable composition
Provided are a curable composition including an amide compound that is represented by Formula (1) below and of which a density of sulfonic acid is 3.9 milliequivalent/g or greater. ##STR00001## m represents an integer of 1 or greater, n represents an integer of 2 or greater, L.sup.1 represents a m+1-valent linking group, and L.sup.2 represents an n-valent linking group. R.sup.1 represents a hydrogen atom or an alkyl group, and R.sup.2 represents SO.sub.3.sup.?M.sup.+ or SO.sub.3R.sup.3 (R.sup.3 represents an alkyl group or an aryl group). Here, in a case where there are plural R.sup.2's, not all of the R.sup.2's are SO.sub.3R.sup.3. M.sup.+ represents a hydrogen ion, an inorganic ion, or an organic ion.
METHOD FOR PRODUCING ALKYLAMINE DERIVATIVE AND ITS PRODUCTION INTERMEDIATE OF ALKYLAMINE DERIVATIVE
A method for producing an alkylamine derivative having a urea bond represented by formula (I), or a salt thereof, comprises the following steps (a) and (b), step (a):
##STR00001##
and step (b): deprotecting as necessary the reaction product obtained in step (a). The production method suitable for industrialization of the alkylamine derivative having a urea bond represented by formula (I), which is a compound highly useful as an agent having CaSR agonist effects is provided.
METHOD FOR PRODUCING ALKYLAMINE DERIVATIVE AND ITS PRODUCTION INTERMEDIATE OF ALKYLAMINE DERIVATIVE
A method for producing an alkylamine derivative having a urea bond represented by formula (I), or a salt thereof, comprises the following steps (a) and (b), step (a):
##STR00001##
and step (b): deprotecting as necessary the reaction product obtained in step (a). The production method suitable for industrialization of the alkylamine derivative having a urea bond represented by formula (I), which is a compound highly useful as an agent having CaSR agonist effects is provided.
METHOD FOR PRODUCING ALKYLAMINE DERIVATIVE AND ITS PRODUCTION INTERMEDIATE OF ALKYLAMINE DERIVATIVE
A method for producing an alkylamine derivative having a urea bond represented by formula (I), or a salt thereof, comprises the following steps (a) and (b), step (a):
##STR00001##
and step (b): deprotecting as necessary the reaction product obtained in step (a). The production method suitable for industrialization of the alkylamine derivative having a urea bond represented by formula (I), which is a compound highly useful as an agent having CaSR agonist effects is provided.
CURABLE COMPOSITION, FUNCTIONAL POLYMER HARDENED PRODUCT, STACK OR DEVICE COMPRISING FUNCTIONAL POLYMER MEMBRANE, AMIDE COMPOUND, AND MANUFACTURING METHOD THEREOF
Provided are a curable composition including an amide compound that is represented by Formula (1) below and of which a density of sulfonic acid is 3.9 milliequivalent/g or greater, a functional polymer hardened product, a stack or a device including a functional polymer membrane, an amide compound, and a manufacturing method thereof.
##STR00001##
m represents an integer of 1 or greater, n represents an integer of 2 or greater, L.sup.1 represents a m+1-valent linking group, and L.sup.2 represents an n-valent linking group. R.sup.1 represents a hydrogen atom or an alkyl group, and R.sup.2 represents SO.sub.3.sup.M.sup.+ or SO.sub.3R.sup.3 (R.sup.3 represents an alkyl group or an aryl group). Here, in a case where there are plural R.sup.2's, not all of the R.sup.2's are SO.sub.3R.sup.3. M.sup.+ represents a hydrogen ion, an inorganic ion, or an organic ion.
CURABLE COMPOSITION, FUNCTIONAL POLYMER HARDENED PRODUCT, STACK OR DEVICE COMPRISING FUNCTIONAL POLYMER MEMBRANE, AMIDE COMPOUND, AND MANUFACTURING METHOD THEREOF
Provided are a curable composition including an amide compound that is represented by Formula (1) below and of which a density of sulfonic acid is 3.9 milliequivalent/g or greater, a functional polymer hardened product, a stack or a device including a functional polymer membrane, an amide compound, and a manufacturing method thereof.
##STR00001##
m represents an integer of 1 or greater, n represents an integer of 2 or greater, L.sup.1 represents a m+1-valent linking group, and L.sup.2 represents an n-valent linking group. R.sup.1 represents a hydrogen atom or an alkyl group, and R.sup.2 represents SO.sub.3.sup.M.sup.+ or SO.sub.3R.sup.3 (R.sup.3 represents an alkyl group or an aryl group). Here, in a case where there are plural R.sup.2's, not all of the R.sup.2's are SO.sub.3R.sup.3. M.sup.+ represents a hydrogen ion, an inorganic ion, or an organic ion.
Stilbene-based reactive compounds, polymeric matrices formed therefrom, and articles visualizable by fluorescence
The invention is directed to latent reactive and polymerizable derivatives of fluorescent stilbene-based compounds. The compounds can be used to provide articles with a fluorescence property, such as medical devices (e.g., catheters). The fluorescent compounds can be used in association with polymers, or can be incorporated into polymers, and the polymers used in a coating composition on the article surface. The compounds allow for visual or machine inspection of coating properties such as uniformity of coverage.
AMINO ACID-BASED COMPOUND FOR DETECTING CARBON DIOXIDE, CARBON DIOXIDE CHEMICAL SENSOR AND CARBON DIOXIDE DETECTION METHOD USING THE SAME
The present invention relates to an amino acid-based compound for detecting carbon dioxide, and to a carbon dioxide chemical sensor and a carbon dioxide detection method using the compound, wherein the compound having selectivity with respect to carbon dioxide exhibits a high selectivity to carbon dioxide and thus may detect carbon dioxide of a very low concentration, exhibits excellent light-absorbing or fluorescent characteristics, and, in particular, may achieve an effect of detecting carbon dioxide in real time.
Alkylamine derivative
A composition containing a compound represented by General Formula (I) below (see the definition in the specification for the symbols in the formula) or a salt thereof has an excellent CaSR agonistic effect and provides a pharmaceutical agent, a CaSR agonistic agent, a prophylactic or therapeutic agent for a disease that can be ameliorated through CaSR activation as well as seasonings and an agent for imparting kokumi. ##STR00001##
Alkylamine derivative
A composition containing a compound represented by General Formula (I) below (see the definition in the specification for the symbols in the formula) or a salt thereof has an excellent CaSR agonistic effect and provides a pharmaceutical agent, a CaSR agonistic agent, a prophylactic or therapeutic agent for a disease that can be ameliorated through CaSR activation as well as seasonings and an agent for imparting kokumi. ##STR00001##